BIO’s Start-up Stadium—Springboard to Success

For those wondering if the Start-up Stadium at the BIO International Convention is worth it, they might consider the experience of Cellanyx, an early stage biomarker test maker who participated in 2017. According to Cellanyx CEO, Dr. Ashok Chander, the Start-up Stadium “…provided exposure and credibility to a new class of investors that may have not already been familiar with the technology and commercialization opportunity.”
Early stage biotech companies face many uphill chal